Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

Molecularly targeted therapies are increasingly relevant in clinical oncology, as they enable the selective modulation of ...

Breast cancer pathogenesis is influenced by various molecular and environmental risk factors. It begins through the mutation of oncogenes, tumor suppressor genes, and dysregulation of key cell ...

Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...

Explore the serious implications of liver congestion and its connections to fibrosis, cirrhosis, and liver cancer in recent ...

Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells ...

Molecular Partners and Orano Med expand collaboration to develop ten 212Pb-Radio-DARPin therapy candidates, initiating clinical trials in 2025. Molecular Partners AG and Orano Med have expanded their ...

How to Keep Up With Molecular Testing and Targeted Therapies in Lung Cancer. If you have the appropriate software installed, you can download article citation data to the citation manager of your ...